Remove 2014 Remove COVID-19 Remove Fraud Remove Governance
article thumbnail

DOJ Releases FY 2021 False Claims Act Recoveries: A Record-Shattering Year for Health Care and Life Sciences Enforcement, with Over $5 Billion Collected

Health Law Advisor

billion, FY 2021 marks DOJ’s largest annual total FCA recovery since FY 2014, and more than twice the $2.3 According to DOJ’s statistics, the government paid out $238 million to relators in FY 2021, the lowest number since FY 2008. With collections amounting to $5.6 billion received in FY 2020. KEY TAKEAWAYS.

Fraud 52
article thumbnail

DOJ Recouped $2.2 Billion Under FCA in 2022

Hall Render

The government initiated 296 FCA cases on its own last year without input of a relator, which is the highest volume of DOJ initiated cases since the 1986 FCA amendments. This has been a growing trend in health care enforcement, and health care fraud remained the leading source of all FCA cases in 2022. COVID-10 Related Fraud.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CMS Issues Contract Year 2023 Final Rule for Medicare Advantage Organizations and Prescription Drug Sponsors

Healthcare Law Blog

Enrollee Participation in Dual Eligible Special Needs Plan (“D-SNP”) Governance (§ 422.107). CMS believes its proposals would improve Federal and State oversight of D-SNPs (and their affiliated MCOs) through greater information-sharing among government regulators.

article thumbnail

The 2021 Shkreli Awards: Lown Institute Counts Down the Top 10 Healthcare Industry Abuses in the Coronavirus Pandemic

Health Populi

Shkreli was ultimately convicted on securities fraud (not related to the Draprim pricing strategy). Early in the pandemic, many hospitals around the country took various punitive actions against staff who spoke out about safety issues on the front line of caring for patients diagnosed with COVID-19. government. (In

article thumbnail

Agree To Disagree – Don’t  Sue the Other Side of a Scientific Dispute into Silence

Drug & Device Law

Opposing attempts to use False Claims Act litigation to adjudicate scientific debate, here , in 2014. Ridiculing a blatantly unconstitutional Missouri statute that sought to silence pharmacists critical of ivermectin and hydroxychloroquine as treatments for COVID-19, just yesterday. American Society of Anesthesiologists, Inc. ,